Schrodinger, Inc. (SDGR) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $895 million, Schrodinger, Inc. is a small-cap company. The stock currently trades at $12.15, up 0.75% today, with a 52-week range of $11.11–$27.63.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-1.41 | $-1.41 | +45.1% | |
| 2024 | $-2.57 | $-2.57 | -575.9% | |
| 2023 | $0.54 | $0.57 | +125.7% | |
| 2022 | $-2.10 | $-2.10 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-25 | 0001490978-26-000010 | SEC ↗ |
| 2024-12-31 | 2025-02-26 | 0001490978-25-000014 | SEC ↗ |
| 2023-12-31 | 2024-02-28 | 0001490978-24-000018 | SEC ↗ |
| 2022-12-31 | 2023-02-28 | 0001490978-23-000024 | SEC ↗ |
| 2021-12-31 | 2022-02-24 | 0001564590-22-006713 | SEC ↗ |
| 2020-12-31 | 2021-03-04 | 0001564590-21-010727 | SEC ↗ |
| 2019-12-31 | 2020-03-16 | 0001564590-20-011182 | SEC ↗ |